- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02141165
Home Nasal Pressure for Sleep Apnea Management in Primary Case (Primary)
Efficacy and Cost-Effectiveness of a Super Simplified System for the Management of Patients With Sleep Apneas in Primary Healthcare.
Primary objectives: To determine the efficacy and cost-effectiveness of a management program for patients with obstructive sleep apnea syndrome (OSAS) carried out in primary or specialist healthcare. In the primary arm, the diagnosis and therapeutic decision will be made by means of a domiciliary nasal pressure (DNP) channel and oximetry while the specialist healthcare arm will use polysomnography (PSG) in a hospital. Patients with an intermediate-high suspicion of OSAS will be included, taking as primary variables the Epworth scale, for efficacy, and the Epworth scale and EuroQol 5D, for cost-effectiveness.
Secondary objectives: efficacy of the two SAHS management programs according to the following secondary variables: a) quality-of-life tests: FOSQ questionnaire, SF36 and analogical wellbeing scale, b) adherence to and compliance with the treatment.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Cáceres, Spanien, 10005
- Juan Fernando Masa Jiménez
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Snoring or apneas objectively observed during sleep by a partner;
- Symptoms that are potentially secondary to apneas/hypopneas with an intermediate-high probability of being treated with CPAP. In operative terms, Epworth scale ≥12 or previous cardiovascular disease;
- Age between 18 and 70 years;
- Absence of any clinical suspicion of any other sleep pathology susceptible to coinciding with daytime sleepiness.
Exclusion Criteria:
- Psycho-physical incapacity to complete questionnaires;
- Documented structural or coronary heart disease uncontrolled by any medical treatment;
- Cheyne-Stokes syndrome;
- Patients subjected to uvulopalatopharyngoplasty;
- Significant nasal obstruction impeding the use of CPAP;
- Pregnancy;
- Lack of informed consent.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Primary.
Diagnosis, autoCPAP, follow up.
|
comparison between the efficacy of two protocol
|
|
Aktiv komparator: Hospital
Diagnosis, autoCPAP, follow up
|
comparison between the efficacy of two protocol
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Efficacy of the extra- and intra-hospital programs using DNP or PSG, taking as primary variable the Epworth scale.
Tidsramme: Before and after 6 months of follow-up
|
Before and after 6 months of follow-up
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Cost-effectiveness of the exta- and intra-hospital management programs using DNP or PSG, evaluated by means of the Epworth scale and EuroQol 5D.
Tidsramme: Before and after 6 months of follow-up
|
Before and after 6 months of follow-up
|
Samarbejdspartnere og efterforskere
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PI13/0238
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Obstruktivt søvnapnøsyndrom
-
Maastricht University Medical CenterEpilepsiecentrum KempenhaegheAfsluttetRolandsk Epilepsi | Landau-Kleffners syndrom | Natlig frontallappens epilepsi | Elektrisk status Epilepticus under Slow Wave SleepHolland
-
Tyco Healthcare GroupUkendt
-
Nanfang Hospital, Southern Medical UniversityRekrutteringKroniske nyresygdomme | OSAS (Obstructive Sleep Apneas Syndrome)Kina
-
Linkoeping UniversityUniversity Hospital, Linkoeping; Amra Medical ABTilmelding efter invitationForhøjet blodtryk | Metabolisk syndrom | Type 2 diabetes | Cirrhose | Sarkopeni | Avanceret fibrose | Fedme & Overvægt | OSAS (Obstructive Sleep Apneas Syndrome) | MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseSverige
Kliniske forsøg med Diagnosis, autoCPAP, follow up.
-
University of WashingtonNational Institute on Aging (NIA); Kaiser PermanenteAfsluttetAdfærdsmæssige symptomer | Demens | Alzheimers sygdom | PlejerbyrdeForenede Stater
-
Northwestern UniversityNorthwestern Memorial HospitalAfsluttetPatient GenindlæggelseForenede Stater
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; Children's Hospital of Philadelphia og andre samarbejdspartnereRekrutteringSelvmord, Forsøg | Selvmord | Selvmordstanker | SelvmordsforebyggelseForenede Stater